Project Number 5U01AG071495-02 Agency/Funding Organization NIA Funding Year 2022 View Full Project Details for Optimization and evaluation of novel benzimidazoles for the treatment of Alzheimer's Disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 2. Tau c. Tau-Mediated Pathogenesis (AD and ADRD) Researcher and Organization Principal Investigator HODGETTS, KEVIN Principal Investigator First Name KEVIN Principal Investigator Last Name HODGETTS Awardee Organization BRIGHAM AND WOMEN'S HOSPITAL Awardee State Massachusetts Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-18-820: Alzheimer's Drug-Development Program (U01 Clinical Trial Optional) FY Overall Cost $943,599 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official REFOLO, LORENZO
